Sunshine Biopharma Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2025
Total Assets: $30.1M
Liabilities Breakdown FY2025
Total Liabilities: $7.0M
Asset Breakdown
Total Assets: $30.1M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $9.1M | 30.3% |
| Accounts Receivable | $3.5M | 11.5% |
| Inventory | $13.5M | 44.8% |
| Property, Plant & Equipment | $557.4K | 1.9% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $1.9M | 6.3% |
| Other Assets | $1.6M | 5.2% |
Liabilities Breakdown
Total Liabilities: $7.0M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $5.7M | 80.4% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $1.4M | 19.6% |